Citigroup
KYTH

Citigroup’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Citigroup’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,390
Closed -$1.08M – 8272
2015
Q3 		$1.08M Sell
14,390
-3,924
-21% -$293K ﹤0.01% 3004
2015
Q2 		$1.38M Buy
18,314
+12,390
+209% +$664K ﹤0.01% 2884
2015
Q1 		$297K Sell
5,924
-3,076
-34% -$129K ﹤0.01% 4172
2014
Q4 		$312K Buy
9,000
+6,814
+312% +$238K ﹤0.01% 4321
2014
Q3 		$72K Sell
2,186
-2,213
-50% -$77.9K ﹤0.01% 5037
2014
Q2 		$169K Sell
4,399
-1,020
-19% -$35.6K ﹤0.01% 4276
2014
Q1 		$216K Sell
5,419
-488
-8% -$21.8K ﹤0.01% 4258
2013
Q4 		$220K Buy
5,907
+5,794
+5,127% +$240K ﹤0.01% 4578
2013
Q3 		$6K Buy
113
+100
+769% +$2.99K ﹤0.01% 6383
2013
Q2 		$0 Buy
+13
New +$297 ﹤0.01% 6865

Citigroup's KYTH Position: Q4 2015 in Review

Citigroup sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 14,390 shares — an estimated $1.08M sold.

Citigroup first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $1.38M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Citigroup reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Citigroup sold 14,390 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $1.08M.
  • Citigroup first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Citigroup's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.38M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Citigroup's 13F filing for Q4 2015, filed 12 Feb 2016.